Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Cognitive Impairment in GI Cancer
NCT05552729Phase 2Unknown
- Sponsor
- Yangzhou University
- Start
- Sep 2022
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised trial of vitamin d in cognitive impairment (3 arms), sponsored by Yangzhou University. Primary endpoint: Cognitive function at 8 days. Status: unknown.
02
Drugs
vitamin d
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT05552729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05552729.